See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Research Area · Pain
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11093 |
4- |
1314230-69-7 | ≥98% |
|
2012-01-30 | 29.832711699173 | 4-quinolone-3-carboxamide-cb2-ligand | 4Q3C CB2 Ligand | CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 | 29.832711699173 | ||
| 11094 |
4- |
1314230-75-5 | ≥98% |
|
2012-02-28 | 32.235202229476 | 4-quinolone-3-carboxamide-furan-cb2-agonist | 4Q3C CB2 Agonist | cannabinoids CBs agonists receptors CB1 CB2 AM630 pain neuroscience osteoporosis inflammation anti-inflammatory bones research peripheral AM630 AM 630 AM-630 | 32.235202229476 | ||
| 9000310 |
8- |
5963-14-4 | ≥98% |
|
2008-10-10 | 5.906419889502 | 8-methyl-nonanoic-acid | Isocapric Acid | capsaicin intermediate bacteria growth substrate antimicrobial capsicum bacterial bacterium | 5.906419889502 | ||
| 10012588 |
A- |
944261-79-4 | ≥98% |
|
2009-02-14 | 0.165745856354 | a-803467 | Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R | 0.165745856354 | |||
| 10010118 | AM1241 | 444912-48-5 | ≥97% |
|
2007-08-29 | 98.893354337934 | am1241 | CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic AM1243 AM-1243 1243 | 98.893354337934 | |||
| 10707 | AM2201 | 335161-24-5 | ≥98% |
|
2011-03-07 | 130.054011314727 | am2201 | cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM-2201 AM 2201 | 130.054011314727 | |||
| 10706 |
AM2201- |
- | ≥99% deuterated forms (d1- d5) |
|
✓ | 2011-05-16 | 53.678816923285 | am2201-d5 | cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards | 53.678816923285 | ||
| 9001029 |
AM2201 N- |
- | ≥98% |
|
✓ | 2011-08-11 | 89.033418511995 | am2201-n-4-fluoropentyl-isomer | forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral | 89.033418511995 | ||
| 10006974 | AM630 | 164178-33-0 | ≥98% |
|
2009-02-09 | 47.443079312365 | am630 | Iodopravadoline | neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors | 47.443079312365 | ||
| 11504 | AM679 Exclusive New | 335160-91-3 | ≥98% |
|
✓ | 2012-04-27 | 108.225876043367 | am679 | ams AM-679 AM 679 central peripheral receptors cannabinoids CBs CB1 CB2 incense agonists forensics spices designer drugs synthetic | 108.225876043367 | ||
| 10567 | AM694 Exclusive | 335161-03-0 | ≥95% |
|
✓ | 2011-01-31 | 60.006351580004 | am694 | cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 | 60.006351580004 | ||
| 13823 | AX 048 Exclusive | 873079-69-7 | ≥98% |
|
✓ | 2010-09-15 | 7.192651933702 | ax-048 | Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids | 7.192651933702 | ||
| 10010088 | CAY10526 Exclusive | 938069-71-7 | ≥98% |
|
✓ | 2007-09-07 | 383.213084714549 | cay10526 | mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions | 383.213084714549 | ||
| 10012565 | CAY10568 | 22913-17-3 | ≥98% |
|
2008-05-28 | 13.160810313075 | cay10568 | Santinamide | TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 | 13.160810313075 | ||
| 10010032 | CAY10570 Exclusive | 875014-22-5 | >98% |
|
✓ | 2008-06-03 | 11.915980662983 | cay10570 | FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids | 11.915980662983 | ||
| 13164 | CAY10589 Exclusive | 1077626-52-8 | ≥98% |
|
✓ | 2009-06-23 | 2.900145027624 | cay10589 | Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling | 2.900145027624 | ||
| 10820 | CAY10651 Exclusive | - | ≥98% |
|
✓ | 2011-06-15 | 0E-12 | cay10651 | Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS | 0E-12 | ||
| 10010398 |
CB- |
432047-72-8 | ≥98% |
|
2009-06-30 | 38.500490737732 | cb-13 | CRA-13 | cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 | 38.500490737732 | ||
| 13289 |
CB- |
1150586-64-3 | ≥98% |
|
✓ | 2010-05-03 | 23.170741910023 | cb-86 | cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Azauridine 6 Azauridine Azauridine cannabinoids cbs synthetic | 23.170741910023 | ||
| 10917 |
(−)- |
114753-51-4 | ≥98% |
|
2011-05-05 | 12.763946616612 | -cp-47-497 | cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 13218 | 12.763946616612 | |||
| 10910 |
(+)- |
134308-14-8 | ≥98% |
|
2011-05-05 | 13.281073688435 | -cp-47-497 | cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids | 13.281073688435 | |||
| 10913 |
(±)- |
70434-82-1 | ≥98% |
|
2011-05-05 | 34.382032339974 | -cp-47-497 | receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 | 34.382032339974 | |||
| 10908 |
(±)- |
70434-92-3 | ≥98% |
|
✓ | 2011-05-06 | 33.614779595787 | -cp-47-497-c8-homolog | CAY10596; Cannabicyclohexanol | cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic | 33.614779595787 | |
| 10686 |
(±)- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-03-14 | 25.726973152059 | -cp-47-497-c8-homolog-d7-solution | Cannabicyclohexanol-d7 | cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 | 25.726973152059 | |
| 13216 |
(±)- |
70434-92-3 | ≥98% |
|
✓ | 2009-04-23 | 43.928671821398 | -cp-47-497-c8-homolog-solution | CAY10596; Cannabicyclohexanol | cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 | 43.928671821398 | |
| 10687 |
(±)- |
- | ≥99% deuterated forms (d1-d11) |
|
✓ | 2011-02-16 | 34.319074410242 | -cp-47-497-d11-solution | receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 | 34.319074410242 | ||
| 13218 |
(−)- |
114753-51-4 | ≥98% |
|
2009-04-13 | 17.412952685231 | -cp-47-497-solution | cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 10917 | 17.412952685231 | |||
| 13219 |
(+)- |
134308-14-8 | ≥98% |
|
2009-04-13 | 18.224339434425 | -cp-47-497-solution | cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 | 18.224339434425 | |||
| 16851 |
(±)- |
70434-82-1 | ≥98% |
|
2008-12-10 | 49.485946899938 | -cp-47-497-solution | receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 | 49.485946899938 | |||
| 13608 |
(+)- |
- | ≥98% |
|
✓ | 2010-05-20 | 22.036376965575 | -cp-55-940 | Δ9-THC cannabinoids CB1 CB2 pain analgesic cannabinoids cbs synthetic | 22.036376965575 | ||
| 13241 |
(±)- |
83003-12-7 | ≥98% |
|
✓ | 2009-05-20 | 21.967687152834 | -cp-55-940 | cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic | 21.967687152834 | ||
| 9000639 | Docosahexaenoyl Serotonin Exclusive | 283601-58-1 | ≥98% |
|
✓ | 2010-05-18 | 6.647182320442 | docosahexaenoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA L-alpha-Glycerylphosphorylcholine L alpha Glycerylphosphorylcholine Glycerophospholipids Choline Choline Glycerophospholipids Phosphoglycerides Choline 3-Phosphocholine Glycerol Glycerylphosphorylcholine Glycerophosphate Choline Glycerol 3-Phosphocholine Glycerol 3 Phosphocholine Choline Phosphoglycerides Glycerophosphorylcholine Choline Glycerophosphate Alphoscerate Choline Phosphatidylcholines Choline Alphoscerate Alfoscerate Choline Phosphatidylcholine Choline Alfoscerate | 6.647182320442 | ||
| 9000640 | Eicosapentaenoyl Serotonin Exclusive | 199875-71-3 | ≥98% |
|
✓ | 2010-09-10 | 2.566314127861 | eicosapentaenoyl-serotonin | N-arachidonoyl serotonins AA-5-HT AA5HT AA 5 HT AA-5HT AA5HT antagonists fatty acids Amide hydrolase FAAH transient receptors potential vanilloid type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Triacylglycerols Triacylglycerol Triglycerides | 2.566314127861 | ||
| 10477 | EP2 Receptor Polyclonal PE Antibody | - | 2010-07-07 | 30.416372007366 | ep2-receptor-polyclonal-pe-antibody | Prostaglandin E2 Receptor 2; PGE2 Receptor 2 | R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons | 30.416372007366 | ||||
| 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | - | Whole-cell lysate | 2008-11-05 | 41.269936858721 | fatty-acid-amide-hydrolase-human-recombinant | FAAH (human recombinant) | FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases active | 41.269936858721 | |||
| 10010182 | Fatty Acid Amide Hydrolase Western Ready Control | - | 66 kDa (His-tagged), 63 kDa (native) | 2007-07-06 | 6.701616022099 | fatty-acid-amide-hydrolase-western-ready-control | Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase | fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors | 6.701616022099 | |||
| 10011347 |
Glycerophospho- |
201738-25-2 | ≥97% |
|
✓ | 2009-03-13 | 18.765230202578 | glycerophospho-n-arachidonoyl-ethanolamine | Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE | anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic | 18.765230202578 | |
| 10224 | GPR55 Polyclonal Antibody | - |
|
2010-01-19 | 42.302316495658 | gpr55-polyclonal-antibody | G Protein-Coupled Receptor 55 | proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic | 42.302316495658 | |||
| 10010372 | GW 842166X | 666260-75-9 | ≥98% |
|
2008-05-23 | 34.145428176795 | gw-842166x | inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic | 34.145428176795 | |||
| 10010410 | GW 848687X | 612831-24-0 | ≥98% |
|
2009-11-25 | 16.795624309392 | gw-848687x | Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X | 16.795624309392 | |||
| 10011038 | Hemopressin | - | 2009-08-13 | 29.761006314127 | hemopressin | peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic | 29.761006314127 | |||||
| 11513 | HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n15f4 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 10215 | IDFP | 615250-02-7 | ≥98% |
|
2009-03-09 | 25.537969613259 | idfp | Isopropyl Dodecylfluorophosphonate | CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids | 25.537969613259 | ||
| 10266 | JWH 007 Exclusive | 155471-10-6 | ≥98% |
|
✓ | 2011-02-23 | 32.475658424607 | jwh-007 | agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 | 32.475658424607 | ||
| 10486 |
JWH 007- |
- | ≥99% deuterated forms (d1-d9) |
|
2010-10-11 | 38.180851749539 | jwh-007-d9 | agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 | 38.180851749539 | |||
| 10900 | JWH 018 | 209414-07-3 | ≥98% |
|
2011-05-05 | 28.369097520404 | jwh-018 | cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 | 28.369097520404 | |||
| 9000844 |
JWH 018 2- |
- | ≥98% |
|
✓ | 2010-10-26 | 19.190639893467 | jwh-018-2-hydroxyindole-metabolite | cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 19.190639893467 | ||
| 10711 |
JWH 018 2- |
- | ≥99% deuterated forms (d1-d9) |
|
✓ | 2011-02-25 | 12.710481456396 | jwh-018-2-hydroxyindole-metabolite-d9 | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 12.710481456396 | ||
| 9000851 |
JWH 018 4- |
- | ≥98% |
|
✓ | 2010-09-01 | 29.965426746809 | jwh-018-4-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 29.965426746809 | ||
| 10712 |
JWH 018 4- |
- | ≥99% deuterated forms (d1-d9) |
|
✓ | 2011-02-25 | 15.974211548210 | jwh-018-4-hydroxyindole-metabolite-d9 | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 15.974211548210 | ||
| 9000852 |
JWH 018 5- |
- | ≥98% |
|
✓ | 2010-09-01 | 31.649293691525 | jwh-018-5-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 31.649293691525 | ||
| 10713 |
JWH 018 5- |
- | ≥99% deuterated forms (d1-d9) |
|
✓ | 2011-03-11 | 16.057740414512 | jwh-018-5-hydroxyindole-metabolite-d9 | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 16.057740414512 | ||
| 9000853 |
JWH 018 6- |
- | ≥98% |
|
✓ | 2010-09-01 | 30.292668565763 | jwh-018-6-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 30.292668565763 | ||
| 10714 |
JWH 018 6- |
- | ≥99% deuterated forms (d1-d9) |
|
✓ | 2011-03-25 | 29.737593084863 | jwh-018-6-hydroxyindole-metabolite-d9 | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 29.737593084863 | ||
| 10697 |
JWH 018 6- |
- | ≥98% |
|
✓ | 2011-02-15 | 19.075558118861 | jwh-018-6-methoxyindole-analog | analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 | 19.075558118861 | ||
| 9000854 |
JWH 018 7- |
- | ≥98% |
|
✓ | 2010-09-01 | 26.744422027828 | jwh-018-7-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 26.744422027828 | ||
| 10715 |
JWH 018 7- |
- | ≥99% deuterated forms (d1-d9) |
|
✓ | 2011-07-26 | 8.456755434286 | jwh-018-7-hydroxyindole-metabolite-d9 | WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 8.456755434286 | ||
| 13824 |
JWH 018- |
- | ≥99% deuterated forms (d1-d9) |
|
2010-06-21 | 48.264956879881 | jwh-018-d9-solution | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 | 48.264956879881 | |||
| 10690 |
JWH 018 N- |
- | ≥97% |
|
✓ | 2011-03-16 | 18.135527365523 | jwh-018-n-2-methylbutyl-isomer | JWH 073 2-methylbutyl homolog | cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 | 18.135527365523 | |
| 10691 |
JWH 018 N- |
- | ≥97% |
|
2011-02-07 | 18.534992637709 | jwh-018-n-3-methylbutyl-isomer | JWH 073 3-methylbutyl homolog | cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 | 18.534992637709 | ||
| 9000855 |
JWH 018 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 112.481585773088 | jwh-018-n-5-hydroxypentyl-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 112.481585773088 | ||
| 10933 |
JWH 018 N- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2011-06-22 | 65.383411098240 | jwh-018-n-5-hydroxypentyl-metabolite-d5 | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 65.383411098240 | ||
| 9000856 |
JWH 018 N- |
- | ≥95% |
|
✓ | 2010-09-01 | 83.447861697431 | jwh-018-n-pentanoic-acid-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 83.447861697431 | ||
| 9000867 |
JWH 018 N- |
- | ≥99% deuterated forms (d1-d4) |
|
✓ | 2010-09-15 | 231.759091679792 | jwh-018-n-pentanoic-acid-metabolite-d4 | JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M | 231.759091679792 | ||
| 13169 | JWH 018 (solution) | 209414-07-3 | ≥98% |
|
2009-03-12 | 47.491561336422 | jwh-018-solution | cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 | 47.491561336422 | |||
| 13633 | JWH 019 | 209414-08-4 | ≥98% |
|
2010-01-14 | 51.392604445863 | jwh-019 | cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 | 51.392604445863 | |||
| 10904 | JWH 073 | 208987-48-8 | ≥97% |
|
2011-05-06 | 35.953065587533 | jwh-073 | cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 | 35.953065587533 | |||
| 10716 |
JWH 073 2- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-03-10 | 13.307377506650 | jwh-073-2-hydroxyindole-metabolite-d7 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 13.307377506650 | ||
| 9000861 |
JWH 073 4- |
- | ≥98% |
|
2010-09-01 | 31.007088490801 | jwh-073-4-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 31.007088490801 | |||
| 10717 |
JWH 073 4- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-02-21 | 6.044669013027 | jwh-073-4-hydroxyindole-metabolite-d7 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 6.044669013027 | ||
| 9000862 |
JWH 073 5- |
- | ≥98% |
|
✓ | 2010-09-01 | 26.670627826984 | jwh-073-5-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 26.670627826984 | ||
| 10718 |
JWH 073 5- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-03-11 | 10.114667254961 | jwh-073-5-hydroxyindole-metabolite-d7 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 10.114667254961 | ||
| 9000863 |
JWH 073 6- |
- | ≥95% |
|
✓ | 2010-09-01 | 24.845264190709 | jwh-073-6-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 24.845264190709 | ||
| 10719 |
JWH 073 6- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-03-11 | 5.957007871222 | jwh-073-6-hydroxyindole-metabolite-d7 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 5.957007871222 | ||
| 9000864 |
JWH 073 7- |
- | 98% |
|
✓ | 2010-09-01 | 20.294200571000 | jwh-073-7-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 20.294200571000 | ||
| 10720 |
JWH 073 7- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-07-25 | 2.962005138349 | jwh-073-7-hydroxyindole-metabolite-d7 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 2.962005138349 | ||
| 9000868 |
JWH 073- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2010-08-10 | 34.439604184391 | jwh-073-d7-solution | deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 | 34.439604184391 | ||
| 10927 |
(±)- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2011-07-25 | 34.000722142645 | -jwh-073-n-3-hydroxybutyl-metabolite-d5 | deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience | 34.000722142645 | ||
| 9000865 |
JWH 073 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 94.571567053504 | jwh-073-n-4-hydroxybutyl-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 94.571567053504 | ||
| 10934 |
JWH 073 N- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2011-10-14 | 60.928260173248 | jwh-073-n-4-hydroxybutyl-metabolite-d5 | M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices | 60.928260173248 | ||
| 9000866 |
JWH 073 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 84.149065798149 | jwh-073-n-butanoic-acid-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 84.149065798149 | ||
| 9000870 |
JWH 073 N- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2010-09-20 | 81.275709907057 | jwh-073-n-butanoic-acid-metabolite-d5 | JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M | 81.275709907057 | ||
| 13170 | JWH 073 (solution) | 208987-48-8 | ≥97% |
|
2009-03-02 | 42.977244992795 | jwh-073-solution | cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 | 42.977244992795 | |||
| 10579 | JWH 081 | 210179-46-7 | ≥98% |
|
2010-10-22 | 63.246342720480 | jwh-081 | cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 | 63.246342720480 | |||
| 10511 |
JWH 081- |
- | ≥99% deuterated forms (d1-d9) |
|
2011-09-08 | 34.895498379446 | jwh-081-d9 | cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS | 34.895498379446 | |||
| 10680 | JWH 098 Exclusive | 316189-74-9 | ≥98% |
|
✓ | 2011-04-20 | 38.943367530193 | jwh-098 | JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles | 38.943367530193 | ||
| 10591 | JWH 122 | 619294-47-2 | ≥98% |
|
2010-12-15 | 91.021638971897 | jwh-122 | JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs 1 2 CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids cbs synthetic | 91.021638971897 | |||
| 10512 |
JWH 122- |
- | ≥99% deuterated forms (d1-d9) |
|
2011-09-08 | 82.701417264663 | jwh-122-d9 | JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS | 82.701417264663 | |||
| 10721 | JWH 201 Exclusive | 864445-47-6 | ≥98% |
|
✓ | 2011-02-24 | 52.971855179095 | jwh-201 | cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 | 52.971855179095 | ||
| 9000736 | JWH 203 | 864445-54-5 | ≥98% |
|
2011-02-21 | 60.724386917343 | jwh-203 | cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic | 60.724386917343 | |||
| 10644 | JWH 210 | 824959-81-1 | ≥98% |
|
2011-02-01 | 91.721299146051 | jwh-210 | cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 | 91.721299146051 | |||
| 10510 |
JWH 210- |
- | ≥99% deuterated forms (d1-d9) |
|
2011-09-08 | 28.281393228426 | jwh-210-d9 | cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain | 28.281393228426 | |||
| 13634 | JWH 250 | 864445-43-2 | ≥98% |
|
2010-01-14 | 81.333491122734 | jwh-250 | cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic | 81.333491122734 | |||
| 10661 |
JWH 250- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2011-02-14 | 37.389532481263 | jwh-250-d5 | cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 | 37.389532481263 | ||
| 10578 | JWH 251 | 864445-39-6 | ≥98% |
|
2010-08-20 | 44.132323069158 | jwh-251 | cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic | 44.132323069158 | |||
| 10722 | JWH 302 Exclusive | 864445-45-4 | ≥95% |
|
✓ | 2011-03-04 | 58.664660429136 | jwh-302 | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding | 58.664660429136 | ||
| 13636 | JWH 398 Exclusive | - | ≥95% |
|
✓ | 2010-10-22 | 75.850922185528 | jwh-398 | jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic | 75.850922185528 | ||
| 13158 | JZL 184 | 1101854-58-3 | ≥97% |
|
2009-01-26 | 215.123167587476 | jzl-184 | 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids | 215.123167587476 | |||
| 13668 | JZL 195 | 121004-12-8 | ≥98% |
|
2010-02-10 | 222.909116022099 | jzl-195 | fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes 1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles | 222.909116022099 | |||
| 9001148 | Ketorolac New | 74103-06-3 | ≥98% |
|
2012-01-12 | 12.447457304307 | ketorolac | Sprix®; Acular PF®; RS 37619; Acular LS® | analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 | 12.447457304307 | ||
| 10009280 |
L- |
174627-50-0 | >98% |
|
2007-09-13 | 33.291215469613 | l-759-633 | L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic | 33.291215469613 | |||
| 10007712 |
L- |
634193-54-7 | ≥98% |
|
✓ | 2010-05-07 | 42.970236779794 | l-902-688 | PGE2 bones growth EP4 agonists hyperalgesia vasodialation | 42.970236779794 | ||
| 13453 | LH 21 | 611207-11-5 | ≥98% |
|
2011-03-22 | 20.343434622468 | lh-21 | cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central | 20.343434622468 | |||
| 9000326 | Linoleoyl Glycine | 2764-03-6 | ≥98% |
|
2008-10-29 | 3.413839779005 | linoleoyl-glycine | N-Linoleoyl Glycine; LinGly; Glycine Linoleamide | arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs | 3.413839779005 | ||
| 10563 | MDA 19 | 1048973-47-2 | ≥95% |
|
2010-09-17 | 47.691606156274 | mda-19 | agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor | 47.691606156274 | |||
| 10639 | MDA 77 Exclusive | 1103774-21-5 | ≥98% |
|
✓ | 2011-05-16 | 2.672099447514 | mda-77 | CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay | 2.672099447514 | ||
| 10007812 | Monoacylglycerol Lipase (human recombinant) | - | >95% |
|
2008-04-01 | 58.963167587477 | monoacylglycerol-lipase-human-recombinant | MAGL; MGL | neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant active | 58.963167587477 | ||
| 10009566 | Monoacylglycerol Lipase Western Ready Control | - | Whole cell lysate | 2007-01-31 | 10.286866614049 | monoacylglycerol-lipase-western-ready-control | MGL; MAGL | hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry | 10.286866614049 | |||
| 10004184 | NESS 0327 Exclusive | 494844-07-4 | >98% |
|
✓ | 2008-05-27 | 34.593259668508 | ness-0327 | neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity | 34.593259668508 | ||
| 9001142 | Norsufentanil Exclusive New | 61086-18-8 | ≥95% |
|
✓ | 2012-04-27 | 186.638524395619 | norsufentanil | R 30451 | noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms | 186.638524395619 | |
| 9001143 |
Norsufentanil- |
1204688-16-3 | ≥99% deuterated forms (d1-d3) |
|
✓ | 2012-04-27 | 161.351168073780 | norsufentanil-d3 | R 30451-d3 | deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms P-450 P 450 | 161.351168073780 | |
| 10007697 |
N- |
136181-87-8 | >98% |
|
2005-11-23 | 5.079447513812 | n-palmitoyl-dopamine | PALDA | N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic | 5.079447513812 | ||
| 10009020 |
N- |
2441-41-0 | ≥98% |
|
2009-12-01 | 2.330883977901 | n-palmitoyl-glycine | N-Hexadecanoyl-Glycine; PalGly | pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines | 2.330883977901 | ||
| 10009195 |
O- |
- | ≥98% |
|
2007-07-12 | 5.521546961326 | o-2545-hydrochloride | cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic | 5.521546961326 | |||
| 10010547 |
O- |
439146-24-4 | >98% |
|
✓ | 2008-03-31 | 19.853933701658 | o-arachidonoyl-glycidol | 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids | 19.853933701658 | ||
| 9000629 | Oleoyl Serotonin Exclusive | 1002100-44-8 | ≥98% |
|
✓ | 2010-05-18 | 6.570323599053 | oleoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase, Palmitoyl CoA CoA Deacylase, Palmitoyl Thioesterase, Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I | 6.570323599053 | ||
| 9000694 |
Oleoyl Serotonin- |
- | ≥99% deuterated forms (d1-d17) |
|
✓ | 2010-09-27 | 6.470165745857 | oleoyl-serotonin-d17 | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards | 6.470165745857 | ||
| 14070 |
ONO- |
216158-34-8 | ≥98% |
|
2011-06-15 | 21.559254143646 | ono-8711 | ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 | 21.559254143646 | |||
| 9000630 | Palmitoyl Serotonin Exclusive | 212707-51-2 | ≥98% |
|
✓ | 2010-05-18 | 7.061310181531 | palmitoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase Palmitoyl CoA CoA Deacylase Palmitoyl Thioesterase Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I | 7.061310181531 | ||
| 13279 |
PF- |
1196109-52-0 | ≥98% |
|
2010-01-27 | 43.794327808471 | pf-3845 | fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal Monoclonal Antibodies | 43.794327808471 | |||
| 10010907 |
PF- |
898235-65-9 | >98% |
|
2008-03-26 | 6.130267743306 | pf-622 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry | 6.130267743306 | |||
| 10010908 |
PF- |
959151-50-9 | >98% |
|
2008-03-25 | 11.054506215470 | pf-750 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry | 11.054506215470 | |||
| 13368 | Piroxicam | 36322-90-4 | ≥95% |
|
2010-01-06 | 3.501417463240 | piroxicam | NSC 666076; Larapam; Feldene | inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 | 3.501417463240 | ||
| 10006973 | Pravadoline | 92623-83-1 | ≥98% |
|
2011-02-08 | 49.868317154124 | pravadoline | WIN 48,098 | Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 | 49.868317154124 | ||
| 13621 | Pristimerin Exclusive | 1258-84-0 | ≥98% |
|
✓ | 2010-03-08 | 49.274348855564 | pristimerin | Celastrol methyl ester; NSC 99281 | monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes | 49.274348855564 | |
| 10007684 |
Prostaglandin D Synthase (lipocalin- |
- |
|
✓ | 2008-06-09 | 14.145262430939 | prostaglandin-d-synthase-lipocalin-type-human-eia-kit | Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit | EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays | 14.145262430939 | ||
| 10384 | Prostaglandin E2 isopropyl ester Exclusive | 71845-66-4 | ≥98% |
|
✓ | 2010-06-07 | 344.740252565114 | prostaglandin-e2-isopropyl-ester | PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic | 344.740252565114 | ||
| 10007939 |
Prostaglandin E Synthase- |
- | 16,000 x g supernatant | 2009-03-15 | 26.335432780847 | prostaglandin-e-synthase-1-microsomal-human-recombinant | Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 | enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 active PTGES | 26.335432780847 | |||
| 10009734 |
Prostaglandin E Synthase- |
- | 2007-05-01 | 10.028004143646 | prostaglandin-e-synthase-1-microsomal-western-ready-control | mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 | western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 PTGES | 10.028004143646 | ||||
| 10011032 |
QX- |
24003-58-5 | ≥98% |
|
2009-02-03 | 0.165745856354 | qx-314-bromide | lidocaine local anesthetic TRPV1 sodium channel blocker pain nociceptor capsaicin | 0.165745856354 | |||
| 10491 |
(R)- |
444912-51-0 | ≥98% |
|
✓ | 2010-05-27 | 38.796531659228 | -r-am1241 | (+)-AM1241 | cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs | 38.796531659228 | |
| 10645 |
RCS- |
- | ≥98% |
|
2010-11-24 | 116.736971034073 | rcs-4 | cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic | 116.736971034073 | |||
| 10513 |
RCS- |
- | ≥99% deuterated product |
|
2011-09-12 | 34.954514656230 | rcs-4-d9 | cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS | 34.954514656230 | |||
| 10636 |
RCS- |
- | ≥98% |
|
2010-11-02 | 98.138615251861 | rcs-8 | SR-18 | cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance A2 Thromboxane Thromboxane A2 | 98.138615251861 | ||
| 500380 | Resolvin D1 EIA Kit New | - |
|
2012-01-13 | 132.393375975472 | resolvin-d1-eia-kit | 17(S)-Resolvin D1; RvD1 | pain ELISAs enzymes immunoassays kits measures measurements resolvins lipids mediators eicosapentaenoic acids EPAs docosahexaenoic DHA inflammation non-inflamed state oxygenation oxygenated 15-lipoxygenase 5 lipoxygenase 15-LO 5-LO 17(R)-RvD1 17(R) epimers aspirin-treatments configurations humans polymorphonuclear leukocytes PMNL transendothelial migrations acute aspirin-triggered murine mouse mice rat model peritonitis inhibition inhibits inhibitors adjuvant-induced arthritis antihyperalgesic effects prevents attenuates post-operative pains transient receptors potentials TRP channels TRPA1 TRPV3 TRP4 anti-nociceptives phagocytes ALX GPR32 insulin sensitivity leptins (db/db) pro-inflammatory macrophages adipose tissues 10007848 17(S)-RvD1 | 132.393375975472 | |||
| 10490 |
(S)- |
444912-53-2 | ≥98% |
|
✓ | 2010-05-27 | 41.957847151487 | -s-am1241 | (-)-AM1241 | cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs | 41.957847151487 | |
| 11019 | SB 366791 | 472981-92-3 | ≥98% |
|
2011-10-13 | 9.380497237569 | sb-366791 | pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 | 9.380497237569 | |||
| 10011561 |
SC- |
146033-02-5 | ≥95% |
|
2010-02-02 | 10.908080110497 | sc-51089 | CID132748 | prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines | 10.908080110497 | ||
| 10010744 |
SC- |
146032-79-3 | >98% |
|
2010-03-09 | 17.113646408840 | sc-51322 | SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos | 17.113646408840 | |||
| 10012555 | Sodium Hydrogen Sulfide (hydrate) | 207683-19-0 | ≥65% |
|
2009-09-03 | 16.287560088776 | sodium-hydrogen-sulfide-hydrate | Sodium Hydrosulfide; NSC 158264; NaHS | hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 | 16.287560088776 | ||
| 9000491 | SR 144528 | 192703-06-3 | ≥98% |
|
2009-08-05 | 72.405013812154 | sr-144528 | antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic | 72.405013812154 | |||
| 9000631 | Stearoyl Serotonin Exclusive | 67964-87-8 | ≥98% |
|
✓ | 2010-05-18 | 6.930797158643 | stearoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Desaturase Stearoyl-CoA Stearoyl-CoA Desaturase Stearoyl CoA Desaturase Desaturase Stearyl-CoA Stearyl-CoA Desaturase Stearyl CoA Desaturase Desaturase Stearate Stearate Desaturase Desaturase delta-9 delta-9 Desaturase | 6.930797158643 | ||
| 13830 | Synthetic Cannabinoid HPLC Mixture I | - | ≥95% for each compound | 2010-05-13 | 40.045118847375 | synthetic-cannabinoid-hplc-mixture-i | cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic | 40.045118847375 | ||||
| 13850 | Synthetic Cannabinoid HPLC Mixture II | - | ≥95% for each compound | 2010-12-21 | 44.388457144890 | synthetic-cannabinoid-hplc-mixture-ii | cannabinoids CBs synthetics mixtures receptors agonists synthetic | 44.388457144890 | ||||
| 11335 | Synthetic Cannabinoid HPLC Mixture III New | - | ≥95% for each compound | 2012-03-20 | 75.250490689850 | synthetic-cannabinoid-hplc-mixture-iii | cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs RCS | 75.250490689850 | ||||
| 11336 | Synthetic Cannabinoid HPLC Mixture IV New | - | ≥95% for each compound | 2012-05-03 | 100.564303915699 | synthetic-cannabinoid-hplc-mixture-iv | cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs | 100.564303915699 | ||||
| 11337 | Synthetic Cannabinoid HPLC Mixture V (AM Series) New | - | ≥95% for each compound | 2012-02-02 | 40.873690480371 | synthetic-cannabinoid-hplc-mixture-v-am-series | AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 | 40.873690480371 | ||||
| 10674 | URB937 Exclusive | 1357160-72-5 | ≥95% |
|
✓ | 2011-03-08 | 15.000916206261 | urb937 | FAAH anandamide AEA inhibitors peripheral pain Cannabinoids | 15.000916206261 | ||
| 10736 | (±)WIN 55212 (mesylate) New | 137795-17-6 | ≥98% |
|
2012-01-11 | 46.514430542014 | -win-55212-mesylate | cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral | 46.514430542014 | |||
| 13665 | YS121 Exclusive | 916482-17-2 | ≥98% |
|
✓ | 2010-04-02 | 17.990220994475 | ys121 | Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 | 17.990220994475 | ||
| 13271 |
ZLJ- |
1051931-39-5 | ≥98% |
|
✓ | 2009-06-17 | 36.043522099447 | zlj-6 | inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 | 36.043522099447 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search